Literature DB >> 2053327

Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants.

M Kojima1, M Shimizu, T Tsuchimochi, M Koyasu, S Tanaka, H Iizuka, T Tanaka, H Okamoto, F Tsuda, Y Miyakawa.   

Abstract

Fulminant hepatitis B developed in 8 recipients of blood units without detectable hepatitis B surface antigen on routine screening. All 124 hepatitis B virus (HBV) DNA clones propagated from their sera possessed defects in the precore region. A point mutation from guanine to adenine at nucleotide 83, converting codon 28 for tryptophan (TGG) to a stop codon (TAG), was the commonest, and it was found in all 113 clones from 7 cases. The remaining case displayed 1 clone with this point mutation and 10 clones with an insertion of 2 base pairs after nucleotide 26. Antibody to hepatitis B core antigen (anti-HBc) was detected in a high titer in 1 of 10 pilot plasma samples of blood units transfused to this case. HBV DNA clones propagated from it exhibited the same precore-region defects as those from the recipient. On the basis of these results HBV mutants, defective in the precore region, would appear to be responsible for posttransfusion fulminant hepatitis B, and the exclusion of blood units with high-titered anti-HBc would be efficacious in preventing it.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2053327     DOI: 10.1111/j.1423-0410.1991.tb00868.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  10 in total

Review 1.  Occult hepatitis B virus infection and blood transfusion.

Authors:  Dong Hee Seo; Dong Hee Whang; Eun Young Song; Kyou Sup Han
Journal:  World J Hepatol       Date:  2015-03-27

2.  Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group.

Authors:  F A Regan; P Hewitt; J A Barbara; M Contreras
Journal:  BMJ       Date:  2000-02-12

3.  Improved detection of hepatitis B virus surface antigen by a new rapid automated assay.

Authors:  B Weber; A Bayer; P Kirch; V Schlüter; D Schlieper; W Melchior
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Preventing Post-Transfusion Hepatitis by screening blood donors for IgM Antibody to Hepatitis B core antigen.

Authors:  Nilima G Sawke; Gk Sawke
Journal:  J Glob Infect Dis       Date:  2010-09

5.  Distribution of hepatitis B viral genotypes and mutations in the core promoter and precore regions in acute forms of liver disease in patients from Chiba, Japan.

Authors:  T Imamura; O Yokosuka; T Kurihara; T Kanda; K Fukai; F Imazeki; H Saisho
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

6.  Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus.

Authors:  Nahed Ismail; Geoffrey E Fish; Michael B Smith
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg.

Authors:  Bernard Weber; Thomas Dengler; Annemarie Berger; Hans Wilhelm Doerr; Holger Rabenau
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

8.  Hook's effect - a rare presentation in HBsAg screening.

Authors:  Kafil Akhtar; Rana K Sherwani; Lateef Ahmad Sofi; Ashish Sharma; Prabhat Singh
Journal:  Indian J Hematol Blood Transfus       Date:  2009-04-06       Impact factor: 0.900

9.  Precore region mutation in hepatitis B virus genome in early stage of infection: a study in hepatitis B e antigen-positive young carriers.

Authors:  X T Nguyen; R Fukuda; S Fukumoto
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

10.  Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Authors:  Christoph Niederhauser
Journal:  J Blood Med       Date:  2011-07-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.